A new study the Department of Cellular and Molecular Medicine identifies a never-before described survival pathway in cancer stem cells (CSCs) that may serve as a potential target for new triple-negative breast cancer (TNBC) treatment therapies.
Fear of breast cancer recurrence is common, unrelated to true risk and does not diminish over time. Irrational fear is debilitating in up to half of patients. Providers can help defuse irrational fear by asking several simple questions.
Join experts from Cleveland Clinic and around the world at a CME-certified official review in Hollywood, Florida.
Cleveland Clinic oncologists conducted a new meta-analysis of breast cancer lumpectomy patients to determine the best margins to prevent additional surgery and optimize long-term survival.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Five-year follow-up data from the Prevention of Early Menopause Study shows use of goserelin, a gonadotropin hormone-releasing hor-mone agonist, along with standard chemotherapy, helps preserve fertility in women with breast cancer.
A retrospective review found that the presence of variants of uncertain significance on multigene panel testing does not increase the rate of contralateral prophylactic mastectomies.
New guidelines for APBI expand its availability to younger patients.
A study comparing healthy and malignant breast tissue found more Methylobacterium in malignant breast tissue.
Depression, anxiety are common in women at genetic risk for breast cancer. Counseling can give them the impetus to embrace preventive measures.
Cleveland Clinic surgeons have developed a technique that expands the indications for nipple-sparing mastectomy beyond small tumors outside of the nipple areolar complex.